898
Z. Song et al. / Tetrahedron Letters 52 (2011) 894–898
15. Xie, J.; Seto, C. T. Bioorg. Med. Chem. 2007, 15, 458–473.
Supplementary data
16. (a) Le Droumaguet, C.; Wang, C.; Wang, Q. Chem. Soc. Rev. 2010, 39, 1233–1239;
(b) Maisonneuve, S.; Fang, Q.; Xie, J. Tetrahedron 2008, 64, 8716–8720; (c) Xie,
J.; Ménand, M.; Maisonneuve, S.; Métivier, R. J. Org. Chem. 2007, 72, 5980–
5985; (d) Hsieh, Y.-C.; Chir, J.-L.; Wu, H.-H.; Wu, A.-T. Tetrahedron Lett. 2010,
51, 109–111; (e) Varazo, K.; Xie, F.; Gulledge, D.; Wang, Q. Tetrahedron Lett.
2008, 49, 5293–5296; (f) Garcia, L.; Maisonneuve, S.; Xie, J.; Guillot, R.; Dorlet,
P.; Rivière, E.; Desmadril, M.; Lambert, F.; Policar, C. Inorg. Chem. 2010, 49,
7282–7288.
Supplementary data associated with this article can be found, in
References and notes
17. (a) Tanaka, N.; Ohnishi, F.; Uchihata, D.; Torii, S.; Nokami, J. Tetrahedron Lett.
2007, 48, 7383–7387; (b) Halmos, T.; Montserret, R.; Filippi, J.; Antonakis, K.
Carbohydr. Res. 1987, 170, 57–69.
18. Zhang, W.; Hong, D.; Zhou, Y.-Y.; Zhang, Y.-N.; Shen, Q.; Li, J.-Y.; Hu, L.-H.; Li, J.
Biochim. Biophys. Acta 2006, 1760, 1505–1512.
19. General procedure for click reaction: To a biphasic solution of di-2-O-propynyl
sugar (1.0 equiv) and the azide 6 (2.2 equiv) in CH2Cl2 (5 mL) and H2O (5 mL),
Na ascorbate (6 equiv) and CuSO4Á5H2O (3 equiv) were added, stirring for 8 h at
rt. The resulting mixture was then directly diluted with CH2Cl2 and washed
with water. The combined organic layers were dried over MgSO4, filtered and
evaporated in vacuum to give a crude residue which was then purified by
column chromatography. Characterization of compound 7. Dimethyl 2,2’-((4,4’-
((((2R,3R,4S,5R,6S)-5-(benzyloxy)-2-((benzyloxy)methyl)-6-methoxytetrahydro-
2H-pyran-3,4-diyl)bis(oxy))bis(methylene))bis(1H-1,2,3-triazole-4,1-diyl))bis(4,1-
phenylene))bis(2-oxoacetate) (7): From compound 5 (270.0 mg, 0.60 mmol) and
1. Bertozzi, C. R.; Kiessling, L. L. Science 2001, 291, 2357–2364.
2. (a) Feizi, T.; Fazio, W.; Chai, W.; Wong, C.-H. Curr. Opin. Struct. Biol. 2003, 13,
637–645; (b) Wu, C.-Y.; Liang, P.-H.; Wong, C.-H. Org. Biomol. Chem. 2009, 7,
2247–2254; (c) Sahabuddin, S.; Chang, T.-C.; Lin, C.-C.; Jan, F.-D.; Hsiao, H.-Y.;
Huang, T.-K.; Chen, J.-H.; Horng, J.-C.; Ho, J.-A. A.; Lin, C.-C. Tetrahedron 2010,
66, 7510–7519.
3. (a) Gamblin, D. P.; Scanlan, E. M.; Davis, B. G. Chem. Rev. 2009, 109, 131–163;
(b) Robinson, M. A.; Charlton, S. T.; Garnier, P.; Wang, X.-T.; Davis, S. S.; Perkins,
A. C.; Frier, M.; Duncan, R.; Savage, T. J.; Wyatt, D. A.; Watson, S. A.; Davis, B. G.
Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 14527–14532.
4. von Rybinski, W.; Hill, K., 2nd ed. In Novel Surfactants Preparation Applications
and Biodegradability; Holmberg, K., Ed.; Marcel Dekker: New York, 2003; Vol.
114, pp 35–93.
5. Ernst, B.; Magnani, J. L. Nat. Rev. Drug Disc. 2009, 8, 661–667.
6. (a) Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Angew. Chem., Int. Ed. 2001, 40, 2004–
2021; (b) Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B. Angew.
Chem., Int. Ed. 2002, 41, 2596–2599.
6
(246.1 mg, 1.2 mmol) afforded 7 as a white powder (411.2 mg, 79.7%).
Rf = 0.25 (EtOAc/petroleum ether, 1:1); [
a
]
D = +58.0 (c 0.4, CH2Cl2); 1H NMR
(400 MHz, CDCl3): d = 8.19–8.15 (m, 4H), 7.93 (s, 1H), 7.74 (d, 2H, J = 8.8 Hz),
7.69 (d, 2H, J = 8.8 Hz), 7.39 (d, 2H, J = 7.2 Hz), 7.35–7.22 (m, 8H), 5.02 (d, 1H,
J = 11.6 Hz), 4.99 (d, 1H, J = 8.4 Hz), 4.97 (d, 1H, J = 8.4 Hz), 4.97 (d, 1H,
J = 7.6 Hz), 4.93–4.88 (m, 2H), 4.80 (d, 1H, J = 12.0 Hz), 4.66 (d, 1H, J = 12.0 Hz),
4.53 (d, 1H, J = 12.0 Hz), 4.02 (s, 6H), 4.00–3.95 (m, 1H), 3.82 (d, 1H,
J = 10.4 Hz), 3.75 (d, 1H, J = 5.2 Hz), 3.71–3.68 (m, 2H), 3.44 (s, 3H); 13C NMR
(100 MHz, CDCl3): d = 184.1, 163.3, 146.4, 141.1, 138.8, 137.9, 132.0, 128.6,
128.4, 127.9, 127.7, 127.6, 127.5, 120.6, 120.3, 120.0, 97.5, 81.6, 79.7, 77.8, 75.5,
7. For recent reviews, see: (a) Aragão-Leoneti, V.; Campo, V. L.; Gomes, A. S.; Field,
R. A.; Carvalho, I. Tetrahedron 2010, 66, 9475–9492; (b) Amblard, F.; Cho, J. H.;
Schinazi, R. F. Chem. Rev. 2009, 109, 4207–4220; (c) Jewett, J. C.; Bertozzi, C. R.
Chem. Soc. Rev. 2010, 39, 1272–1279.
8. (a) Lee, L. V.; Mitchell, M. L.; Huang, S.-J.; Fokin, V. V.; Sharpless, K. B.; Wong, C.-
H. J. J. Am. Chem. Soc. 2003, 125, 9588–9589; (b) Lu, W.-Y.; Sun, X.-W.; Zhu, C.;
Xu, J.-H.; Lin, G.-Q. Tetrahedron 2010, 66, 750–757; (c) Pereira, G. R.; Santos, L.
J.; Luduvico, I.; Alves, R. B.; Pereira de Freitas, R. Tetrahedron Lett. 2010, 51,
1022–1025; (d) Ameen, M. A.; Karsten, S.; Fenger, R.; Liebscher, J. Tetrahedron
Lett. 2010, 51, 4328–4330; (e) Abdu-Allah, H. H. M.; Watanabe, K.; Hayashizaki,
K.; Iwayama, Y.; Takematsu, H.; Kozutsumi, Y.; Tsubata, T.; Ishida, H.; Kiso, M.
Tetrahedron Lett. 2009, 50, 4488–4491; (f) Neto, V.; Granet, R.; Krausz, P.
Tetrahedron 2010, 66, 4633–4636; (g) Song, S.-X.; Zhang, H.-L.; Kim, C.-G.;
Sheng, L.; He, X.-P.; Long, Y.-T.; Li, J.; Chen, G.-R. Tetrahedron 2010, 66, 9974–
9980.
73.6, 70.1, 68.4, 65.9, 64.2, 55.3, 53.1; HRMS: calcd for
C45H44N6O12+H:
861.3095, found: 861.3096. Characterization of compound 8. Methyl 2-(4-(4-
((((2S,3R,4S,5R,6R)-4,5-bis(benzyloxy)-2-methoxy-6-(((1-(4-(2-methoxy-2-
oxoacetyl)phenyl)-1H-1,2,3-triazol-4-yl)methoxy)methyl)tetrahydro-2H-pyran-3-
yl)oxy)methyl)-1H-1,2,3-triazol-1-yl)phenyl)-2-oxoacetate (8): From compound
2 (207.1 mg, 0.46 mmol) and 6 (188.6 mg, 0.92 mmol) afforded 8 as a white
powder (343.1 mg, 86.7%). Rf = 0.23 (EtOAc/petroleum ether, 1:1); [a]D = +20.4
(c 0.1, CH2Cl2); 1H NMR (400 MHz, CDCl3): d = 8.21 (d, 2H, J = 8.4 Hz), 8.13 (d,
2H, J = 8.4 Hz), 8.01 (s, 1H), 7.86 (s, 1H), 7.83 (d, 2H, J = 8.8 Hz), 7.63 (d, 2H,
J = 8.8 Hz), 7.40–7.17 (m, 10H), 5.17 (d, 1H, J = 12.8 Hz), 5.09 (d, 1H,
J = 12.8 Hz), 4.87 (d, 1H, J = 11.2 Hz), 4.83 (d, 1H, J = 12.8 Hz), 4.80 (d, 1H,
J = 12.0 Hz), 4.74–4.68 (m, 3H), 4.60 (d, 1H, J = 11.2 Hz), 4.02 (s, 6H), 4.00 (t, 1H,
J = 9.6 Hz), 3.88 (dd, 1H, J = 3.2, 10.0 Hz), 3.80–3.77 (m, 2H), 3.62 (t, 1H,
J = 9.2 Hz), 3.58 (dd, 1H, J = 3.6, 9.6 Hz), 3.39 (s, 3H); 13C NMR (100 MHz,
CDCl3): d = 184.3, 163.1, 147.0, 146.0, 141.1, 141.0, 138.2, 138.0, 132.1, 132.0,
131.9, 131.8, 128.5, 128.4, 128.0, 127.9, 127.7, 127.4, 120.3, 120.0, 119.8, 97.7,
81.5, 80.0, 74.8, 73.1, 68.9, 66.3, 64.6, 55.3, 53.0; HRMS: calcd for
9. Agard, N. J.; Prescher, J. A.; Bertozzi, C. R. J. Am. Chem. Soc. 2004, 126, 15046–
15047.
10. Laughlin, S. T.; Baskin, J. M.; Amacher, S. L.; Bertozzi, C. R. Science 2008, 320,
664–667.
11. (a) Praly, J.-P.; He, L.; Qin, B. B.; Tanoh, M.; Chen, G.-R. Tetrahedron Lett. 2005,
46, 7081–7085; (b) Lin, L.; Shen, Q.; Chen, G.-R.; Xie, J. Bioorg. Med. Chem. 2008,
16, 9747–9763.
12. Zhang, S.; Zhang, Z.-Y. Drug Discovery Today 2007, 12, 373–381.
13. Puius, Y. A.; Zhao, Y.; Sullivan, M.; Lawrence, D. S.; Almo, S. C.; Zhang, Z.-Y. Proc.
Natl. Acad. Sci. U.S.A. 1997, 94, 13420–13425.
C
45H44N6O12+H: 861.3095, found: 861.3096.
14. (a) Ziegler, T.; Hermann, C. Tetrahedron Lett. 2008, 49, 2166–2169; (b) Camp, C.;
Dorbes, S.; Picard, C.; Benoist, E. Tetrahedron Lett. 2008, 49, 1979–1983.